Heart Rhythm

Article	Citations
COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors	223
2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families	180
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure	158
Left bundle branch–optimized cardiac resynchronization therapy (LOT-CRT): Results from an international LBBAP collaborative study group	134
Clinical outcomes of left bundle branch area pacing compared to right ventricular pacing: Results from the Geisinger-Rush Conduction System Pacing Registry	131
Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials	126
Physiology-based electrocardiographic criteria for left bundle branch capture	122
The possible association between COVID-19 and postural tachycardia syndrome	107
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Gen	100
Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial	100
Clinical outcomes of conduction system pacing compared to biventricular pacing in patients requiring cardiac resynchronization therapy	94
Marshall bundle elimination, Pulmonary vein isolation, and Line completion for ANatomical ablation of persistent atrial fibrillation (Marshall-PLAN): Prospective, single-center study	90
Intermediate-term performance and safety of His-bundle pacing leads: A single-center experience	88
Left bundle branch pacing compared to left ventricular septal myocardial pacing increases interventricular dyssynchrony but accelerates left ventricular lateral wall depolarization	80
Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection	80
Epicardial course of the septopulmonary bundle: Anatomical considerations and clinical implications for roof line completion	74
Postural orthostatic tachycardia syndrome as a sequela of COVID-19	71
Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations	68
Off-label dosing of non–vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation	66
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients	62
Fixation beats: A novel marker for reaching the left bundle branch area during deep septal lead implantation	60
Rescue left bundle branch area pacing in coronary venous lead failure or nonresponse to biventricular pacing: Results from International LBBAP Collaborative Study Group	59
Electrophysiological characteristics of septal perforation during left bundle branch pacing	56
Effects of hydroxychloroquine treatment on QT interval	54
Catheter ablation of atrial fibrillation using ablation index–guided high power (50 W) for pulmonary vein isolation with or without esophageal temperature probe (the AI-HP ESO II)	54

Cardioneuroablation for vasovagal syncope: A systematic review and meta-analysis	53
Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator	51
A circadian clock in the sinus node mediates day-night rhythms in Hcn4 and heart rate	49
Validation of an algorithm for continuous monitoring of atrial fibrillation using a consumer smartwatch	49
His-bundle and left bundle pacing with optimized atrioventricular delay achieve superior electrical synchrony over endocardial and epicardial pacing in left bundle branch block patients	49
High-throughput discovery of trafficking-deficient variants in the cardiac potassium channel KV11.1	43
His-bundle pacing vs biventricular pacing following atrioventricular nodal ablation in patients with atrial fibrillation and reduced ejection fraction: A multicenter, randomized, crossover study—The A	43
Cardiac potassium inward rectifier Kir2: Review of structure, regulation, pharmacology, and arrhythmogenesis	41
Subcutaneous versus transvenous implantable defibrillator: An updated meta-analysis	40
Ectopy-triggering ganglionated plexuses ablation to prevent atrial fibrillation: GANGLIA-AF study	40
Leadless left ventricular stimulation with WiSE-CRT System – Initial experience and results from phase I of SOLVE-CRT Study (nonrandomized, roll-in phase)	40
Filamin-C variant-associated cardiomyopathy: A pooled analysis of individual patient data to evaluate the clinical profile and risk of sudden cardiac death	40
Major adverse clinical events associated with implantation of a leadless intracardiac pacemaker	39
Bipolar radiofrequency ablation for ventricular tachycardias originating from the interventricular septum: Safety and efficacy in a pilot cohort study	39
Predictors of atrial mechanical sensing and atrioventricular synchrony with a leadless ventricular pacemaker: Results from the MARVEL 2 Study	38
Atrial fibrillation burden and heart failure: Data from 39,710 individuals with cardiac implanted electronic devices	37
Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: Real-world data from the extended ELISIR experience	37
Pacing-induced cardiomyopathy: A systematic review and meta-analysis of definition, prevalence, risk factors, and management	37
Contrast-enhanced image-guided lead deployment for left bundle branch pacing	36
Temperature monitoring and temperature-driven irrigated radiofrequency energy titration do not prevent thermally induced esophageal lesions in pulmonary vein isolation: A randomized study controlled b	36
Atrioventricular junction ablation in patients with conduction system pacing leads: A comparison of His-bundle vs left bundle branch area pacing leads	35
Leadless atrioventricular synchronous pacing in an outpatient setting: Early lessons learned on factors affecting atrioventricular synchrony	35
Recommendations regarding cardiac stereotactic body radiotherapy for treatment refractory ventricular tachycardia	33
Temperature- and flow-controlled ablation/very-high-power short-duration ablation vs conventional power-controlled ablation: Comparison of focal and linear lesion characteristics	33
Structure and function of the ventricular tachycardia isthmus	33
Scar channels in cardiac magnetic resonance to predict appropriate therapies in primary prevention	33
Differentiating hereditary arrhythmogenic right ventricular cardiomyopathy from cardiac sarcoidosis fulfilling 2010 ARVC Task Force Criteria	32
Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: A randomized controlled trial	32
SCAI/HRS expert consensus statement on transcatheter left atrial appendage closure	32
Cardiac arrhythmias and sudden unexpected death in epilepsy: Results of long-term monitoring	31
Smartwatch-based detection of cardiac arrhythmias: Beyond the differentiation between sinus rhythm and atrial fibrillation	31
Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trial	31
Prevalence and outcome of early recurrence of atrial tachyarrhythmias in the Cryoballoon vs Irrigated Radiofrequency Catheter Ablation (CIRCA-DOSE) study	30
2023 HRS/EHRA/APHRS/LAHRS expert consensus statement on practical management of the remote device clinic	30
Comparison of the effect of glucose-lowering agents on the risk of atrial fibrillation: A network meta-analysis	29
Repeated exposure to transient obstructive sleep apnea–related conditions causes an atrial fibrillation substrate in a chronic rat model	29
Computer versus cardiologist: Is a machine learning algorithm able to outperform an expert in diagnosing a phospholamban p.Arg14del mutation on the electrocardiogram?	29
2023 HRS expert consensus statement on the management of arrhythmias during pregnancy	29
Nationwide burden of sudden cardiac death: A study of 54,028 deaths in Denmark	28
Does pulsed field ablation regress over time? A quantitative temporal analysis of pulmonary vein isolation	28
Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with	28
Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval	27
Relationship of paced left bundle branch pacing morphology with anatomic location and physiological outcomes	27
Predictive value of atrial fibrillation during the postradiofrequency ablation blanking period	27
Ventricular tachycardia burden reduction after substrate ablation: Predictors of recurrence	26
Cybersecurity: The need for data and patient safety with cardiac implantable electronic devices	26
Letter to the Editor—Lifesaving therapy inhibition by phones containing magnets	26
Clinical profile and long-term follow-up of a cohort of patients with desmoplakin cardiomyopathy	26
Common and rare susceptibility genetic variants predisposing to Brugada syndrome in Thailand	25
Remote and wearable ECG devices with diagnostic abilities in adults: A state-of-the-science scoping review	25

The role of timing in treatment of atrial fibrillation: An AFFIRM substudy	24
Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation	24
Left ventricular summit arrhythmias with an abrupt V3 transition: Anatomy of the aortic interleaflet triangle vantage point	23
Electrical and structural remodeling contribute to atrial fibrillation in type 2 diabetic db/db mice	23
High-density epicardial mapping in Brugada syndrome: Depolarization and repolarization abnormalities	23
Self-reported physical activity and atrial fibrillation risk: A systematic review and meta-analysis	23
Epicardial course of the musculature related to the great cardiac vein: Anatomical considerations and clinical implications for mitral isthmus block after vein of Marshall ethanol infusion	22
Vein of Marshall ethanol infusion in the treatment of atrial fibrillation: From concept to clinical practice	22
Impact of timing of transvenous lead removal on outcomes in infected cardiac implantable electronic devices	22
Identification of important risk factors for all-cause mortality of acquired long QT syndrome patients using random survival forests and non-negative matrix factorization	22
Combined epicardial and endocardial ablation for atrial fibrillation: Best practices and guide to hybrid convergent procedures	22
Very long term outcomes of atrial fibrillation ablation	22
Safety of leadless pacemaker implantation in the very elderly	22
Systematic quantification of histologic ventricular fibrosis in isolated mitral valve prolapse and sudden cardiac death	22
Frailty in patients undergoing percutaneous left atrial appendage closure	22
Multisite conduction block in the epicardial substrate of Brugada syndrome	22
Pericardial effusion requiring intervention in patients undergoing percutaneous left atrial appendage occlusion: Prevalence, predictors, and associated in-hospital adverse events from 17,700 procedure	22
Role of subcutaneous implantable loop recorder for the diagnosis of arrhythmias in Brugada syndrome: A United Kingdom single-center experience	22
2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders	22
Left atrial appendage occlusion using intracardiac echocardiography	21
Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis	21
Long-term survival following transvenous lead extraction: Importance of indication and comorbidities	21
Venous anatomy of the left ventricular summit: Therapeutic implications for ethanol infusion	21
Effects of pulsed field ablation on autonomic nervous system in paroxysmal atrial fibrillation: A pilot study	21
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Executive Summary	20
Extracellular matrix remodeling precedes atrial fibrillation: Results of the PREDICT-AF trial	20
Dexmedetomidine versus propofol for operator-directed nurse-administered procedural sedation during catheter ablation of atrial fibrillation: A randomized controlled study	20
Connexin45 (GJC1) loss-of-function mutation contributes to familial atrial fibrillation and conduction disease	20
Calcium signaling consequences of RyR2 mutations associated with CPVT1 introduced via CRISPR/Cas9 gene editing in human-induced pluripotent stem cell–derived cardiomyocytes: Comparison of RyR2-R420Q,	20
Blood-based 8-hydroxy-2′-deoxyguanosine level: A potential diagnostic biomarker for atrial fibrillation	20
Tricuspid regurgitation outcomes in left bundle branch area pacing and comparison with right ventricular septal pacing	20
Gain in real-world cardiac resynchronization therapy efficacy with SyncAV dynamic optimization: Heart failure hospitalizations and costs	20
Outcomes of leadless pacemaker implantation following transvenous lead extraction in high-volume referral centers: Real-world data from a large international registry	20
Defining idiopathic ventricular fibrillation: A systematic review of diagnostic testing yield in apparently unexplained cardiac arrest	20
Mechanism of the effects of sodium channel blockade on the arrhythmogenic substrate of Brugada syndrome	20
Is transesophageal echocardiography necessary in patients undergoing ablation of atrial fibrillation on an uninterrupted direct oral anticoagulant regimen? Results from a prospective multicenter regis	20
Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy—Are there predictors of appropriate therapy?	19
Absence of (sub-)acute cerebral events or lesions after electroporation ablation in the left-sided canine heart	19
B-PO03-131 EFFECTS OF CONTACT FORCE ON LESION SIZE DURING PULSED FIELD ABLATION	19
Atrial arrhythmias and patient-reported outcomes in adults with congenital heart disease: An international study	19
Effect of pacemaker implantation after transcatheter aortic valve replacement on long- and mid-term mortality	19
Anticoagulation for stroke prevention in patients with hypertrophic cardiomyopathy and atrial fibrillation: A review	19
Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises	19
Association between nocturnal heart rate variability and incident cardiovascular disease events: The HypnoLaus population-based study	19
Current of injury is an indicator of lead depth and performance during left bundle branch pacing lead implantation	19
Clinical outcomes of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy: Insights from the Johns Hopkins ARVC Program	19
Secretome of atrial epicardial adipose tissue facilitates reentrant arrhythmias by myocardial remodeling	19
Individualized ablation strategy to treat persistent atrial fibrillation: Core-to-boundary approach guided by charge-density mapping	19
Cerebral safety after pulsed field ablation for paroxysmal atrial fibrillation	18
Ventricular arrhythmias in athletes: Role of a comprehensive diagnostic workup	18
Sinus node exit, crista terminalis conduction, interatrial connection, and wavefront collision: Key features of human atrial activation in sinus rhythm	18
Double-balloon technique for retrograde venous ethanol ablation of ventricular arrhythmias in the absence of suitable intramural veins	18
Discrete sites of frequent premature ventricular complexes cluster within the infarct border zone and coincide with high frequency of delayed afterdepolarizations under adrenergic stimulation	18
Cardiac deceleration capacity as an indicator for cardioneuroablation in patients with refractory vasovagal syncope	18
Effect of electrode size and spacing on electrograms: Optimized electrode configuration for near-field electrogram characterization	18
Staphylococcus bacteremia without evidence of cardiac implantable electronic device infection	18
Optimizing lead placement for pacing in dyssynchronous heart failure: The patient in the lead	18
Age-related differences and associated mid-term outcomes of subcutaneous implantable cardioverter-defibrillators: A propensity-matched analysis from a multicenter European registry	18
Outcomes of conduction system pacing for cardiac resynchronization therapy in patients with heart failure: A multicenter experience	18
Static magnetic field measurements of smart phones and watches and applicability to triggering magnet modes in implantable pacemakers and implantable cardioverter-defibrillators	18
Critical repolarization gradients determine the induction of reentry-based torsades de pointes arrhythmia in models of long QT syndrome	18
Predictors of loss of capture in left bundle branch pacing: A multicenter experience	18
Biventricular endocardial pacing and left bundle branch area pacing for cardiac resynchronization: Mechanistic insights from electrocardiographic imaging, acute hemodynamic response, and magnetic reso	18
Distance between the lead-implanted site and tricuspid valve annulus in patients with left bundle branch pacing: Effects on postoperative tricuspid regurgitation deterioration	18
Incidence of new-onset atrial fibrillation after transcatheter patent foramen ovale closure using 15 years of Ontario administrative health data	17
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial	17
Procedural and short-term follow-up outcomes of Amplatzer Amulet occluder versus Watchman FLX device: A meta-analysis	17
Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke	17
Pursue physiological pacing therapy: A better understanding of left bundle branch pacing and left ventricular septal myocardial pacing	17
Cardiovascular exercise as a treatment of postural orthostatic tachycardia syndrome: A pragmatic treatment trial	17
Feasibility of leadless left ventricular septal pacing with the WiSE-CRT system to target the left bundle branch area: A porcine model and multicenter patient experience	17
Evaluation of European Heart Rhythm Association consensus in patients with cardiovascular implantable electronic devices and Staphylococcus aureus bacteremia	17
Predicting arrhythmic event score in Brugada syndrome: Worldwide pooled analysis with internal and external validation	17
Long-term performance of a novel communicating antitachycardia pacing–enabled leadless pacemaker and subcutaneous implantable cardioverter-defibrillator system: A comprehensive preclinical study	17
Preclinical safety and electrical performance of novel atrial leadless pacemaker with dual-helix fixation	16
Macroreentrant biatrial tachycardia relevant to interatrial septal incisions after mitral valve surgery: Electrophysiological characteristics and ablation strategy	16
Predictors of perforation during lead extraction: Results of the Canadian Lead ExtrAction Risk (CLEAR) study	16
Pulsed-field ablation versus single-catheter high-power short-duration radiofrequency ablation for atrial fibrillation: Procedural characteristics, myocardial injury, and mid-term outcomes	16
Sex differences in the origin of Purkinje ectopy-initiated idiopathic ventricular fibrillation	16
Noninvasive electrocardiographic imaging–guided targeting of drivers of persistent atrial fibrillation: The TARGET-AF1 trial	16

QT prolongation in patients with index evaluation for seizure or epilepsy is predictive of all-cause mortality	16
Electrophysiological characteristics and possible mechanism of bipolar pacing in left bundle branch pacing	16
Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker	16
Ambulatory atrioventricular synchronous pacing over time using a leadless ventricular pacemaker: Primary results from the AccelAV study	16
Catheter-free ablation of infarct scar through proton beam therapy: Tissue effects in a porcine model	16
Evaluation of age at symptom onset, proband status, and sex as predictors of disease severity in pediatric catecholaminergic polymorphic ventricular tachycardia	16
Reconsidering the multiple wavelet hypothesis of atrial fibrillation	16
Sinus Node Sparing Hybrid Thoracoscopic Ablation Outcomes in Patients with Inappropriate Sinus Tachycardia (SUSRUTA-IST) Registry	15
Reduction in atrial and pulmonary vein stretch as a therapeutic target for prevention of atrial fibrillation	15
Cardiac resynchronization therapy and ventricular tachyarrhythmia burden	15
Anterior mitral line in patients with persistent atrial fibrillation and anterior scar: A multicenter matched comparison—The MiLine study	15
Intramyocardial mapping of ventricular premature depolarizations via septal venous perforators: Differentiating the superior intraseptal region from left ventricular summit origins	15
Segmental nonocclusive cryoballoon ablation of pulmonary veins and extrapulmonary vein structures: Best practices III	15
Leadless left ventricular endocardial pacing for cardiac resynchronization therapy: A systematic review and meta-analysis	15
Rate and nature of complications of conduction system pacing compared with right ventricular pacing: Results of a propensity score–matched analysis from a multicenter registry	15
R-on-T and the initiation of reentry revisited: Integrating old and new concepts	15
Impact of myocardial fiber orientation on lesions created by a novel heated saline-enhanced radiofrequency needle-tip catheter: An MRI lesion validation study	14
Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up	14
Ischemia-induced ventricular proarrhythmia and cardiovascular autonomic dysreflexia after cardioneuroablation	14
SCN5A mutation in Brugada syndrome is associated with substrate severity detected by electrocardiographic imaging and high-density electroanatomic mapping	14
Bachmann bundle potential during atrial lead placement: A case series	14
Trends in utilization and spending on remote monitoring of pacemakers and implantable cardioverter–defibrillators among Medicare beneficiaries	14
Serum exosomal long noncoding RNAs as a diagnostic biomarker for atrial fibrillation	14
Importance of newer cardiac magnetic resonance–based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study	14
Percutaneous management of superior vena cava syndrome in patients with cardiovascular implantable electronic devices	14
Prior myocarditis and ventricular arrhythmias: The importance of scar pattern	14
Subcutaneous implantable cardioverter-defibrillator and defibrillation testing: A propensity-matched pilot study	14
Genetic basis of sudden death after COVID-19 vaccination in Thailand	14
Increased vulnerability to atrial and ventricular arrhythmias caused by different types of inhaled tobacco or marijuana products	14
Prognostic value of cardiac magnetic resonance septal late gadolinium enhancement patterns for periaortic ventricular tachycardia ablation: Heterogeneity of the anteroseptal substrate in nonischemic c	13
How to use bipolar and unipolar electrograms for selecting successful ablation sites of ventricular premature contractions	13
Reassessing the role of antitachycardia pacing in fast ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Results from MADIT-RIT	13
Atrial resting membrane potential confers sodium current sensitivity to propafenone, flecainide and dronedarone	13
Impacts of frailty on heart rate variability in aging mice: Roles of the autonomic nervous system and sinoatrial node	13
A novel Ventricular map of Electrograms DUration as a Method to identify areas of slow conduction for ventricular tachycardia ablation: The VEDUM pilot study	13
Subcutaneous versus transvenous implantable defibrillator in patients with hypertrophic cardiomyopathy	13
A phenotype-enhanced variant classification framework to decrease the burden of missense variants of uncertain significance in type 1 long QT syndrome	13
Simultaneous epicardial–endocardial mapping of the sinus node in humans with structural heart disease: Impact of overdrive suppression on sinoatrial exits	13
Alcohol consumption and risk of ventricular arrhythmias and sudden cardiac death: An observational study of 408,712 individuals	13
Electrical storm in patients with left ventricular assist devices: Risk factors, incidence, and impact on survival	13
Malignant Purkinje ectopy induced by sodium channel blockers	13
Long-term prognosis of women with Brugada syndrome and electrophysiological study	13
Arrhythmia-induced cardiomyopathy: A potentially reversible cause of refractory cardiogenic shock requiring venoarterial extracorporeal membrane oxygenation	13
The importance of early evaluation after cardiac resynchronization therapy to redefine response: Pooled individual patient analysis from 5 prospective studies	13
Active compression versus standard anterior-posterior defibrillation for external cardioversion of atrial fibrillation: A prospective randomized study	13
Implant, performance, and retrieval of an atrial leadless pacemaker in sheep	13
Implantation of cardiac electronic devices in active COVID-19 patients: Results from an international survey	13
How to perform ethanol ablation of the vein of Marshall for treatment of atrial fibrillation	13
Renal denervation prevents subclinical atrial fibrillation in patients with hypertensive heart disease: Randomized, sham-controlled trial	13
Risk of sudden cardiac death associated with QRS, QTc, and JTc intervals in the general population	13
Quality of life after the initial treatment of atrial fibrillation with cryoablation versus drug therapy	13
Electrophysiology studies for predicting atrioventricular block in patients with syncope: A systematic review and meta-analysis	12
Temporal and geographical trends in women operators of electrophysiology procedures in the United States	12
Machine learning for distinguishing right from left premature ventricular contraction origin using surface electrocardiogram features	12
Atrial fibrillation in the presence and absence of heart failure enhances expression of genes involved in cardiomyocyte structure, conduction properties, fibrosis, inflammation, and endothelial dysfun	12
Skin sympathetic nerve activity in patients with obstructive sleep apnea	12
Impact of early ventricular tachycardia ablation in patients with an implantable cardioverter-defibrillator: An updated systematic review and meta-analysis of randomized controlled trials	12
Ultrasound-guided extracardiac vagal stimulation—New approach for visualization of the vagus nerve during cardioneuroablation	12
Catheter ablation of intra-atrial reentrant/focal atrial tachycardia in adult congenital heart disease: Value of final programmed atrial stimulation	12
Clinician needs and perceptions about cardioneuroablation for recurrent vasovagal syncope: An international clinician survey	12
Incidence of life-threatening events in children with Wolff-Parkinson-White syndrome: Analysis of a large claims database	12
The precordial R′ wave: A novel discriminator between cardiac sarcoidosis and arrhythmogenic right ventricular cardiomyopathy in patients presenting with ventricular tachycardia	12
Factors associated with remote monitoring adherence for cardiovascular implantable electronic devices	12
Successful avoidance of superior vena cava injury during transvenous lead extraction using a tandem femoral-superior approach	12
To the Editor—New phones, old problem? Interference with cardiovascular implantable electronic devices by phones containing magnets	12
Competing risks in patients with primary prevention implantable cardioverter-defibrillators: Global Electrical Heterogeneity and Clinical Outcomes study	12
Device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients	12
The impact of heart rate circadian rhythm on in-hospital mortality in patients with stroke and critically ill: Insights from the eICU Collaborative Research Database	12
Racial disparities in the utilization and in-hospital outcomes of percutaneous left atrial appendage closure among patients with atrial fibrillation	12
In vitro modeling accurately predicts cardiac lead fracture at 10 years	11
Impact of specialized electrophysiological care on the outcome of catheter ablation for supraventricular tachycardias in adults with congenital heart disease: Independent risk factors and gender aspec	11
Troponin release after pulmonary vein isolation using pulsed field ablation compared to radiofrequency and cryoballoon ablation	11
Early trends in leadless pacemaker implantation: Evaluating nationwide in-hospital outcomes	11
Genetic analysis identifies the SLC4A3 anion exchanger as a major gene for short QT syndrome	11
Optimizing atrial sensing parameters in leadless pacemakers: Atrioventricular synchrony achievement in the real world	11
Tissues attached to retrieved leadless pacemakers: Histopathological evaluation of tissue composition in relation to implantation time and complications	11
A novel approach to mapping and ablation of septal outflow tract ventricular arrhythmias: Insights from multipolar intraseptal recordings	11
Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval Study	11
Novel pathogenic role for galectin-3 in early disease stages of arrhythmogenic cardiomyopathy	11
Right bundle branch block ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy more commonly originates from the right ventricle: Criteria for identifying chamber of origin	11
Differentiating atrial tachycardias with centrifugal activation: Lessons from high-resolution mapping	11
Right bundle branch pacing: Criteria, characteristics, and outcomes	11
Permanent pacemaker implantation late after transcatheter aortic valve implantation	11
Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator	11
High-resolution parahisian mapping and ablation using microelectrode embedded ablation catheters	11
Predictors and outcomes of in-hospital referrals for forensic investigation after young sudden cardiac death	11
Global electrical heterogeneity associated with drug-induced torsades de pointes	11
A governing equation for rotor and wavelet number in human clinical ventricular fibrillation: Implications for sudden cardiac death	11
Genome sequencing in a genetically elusive multigenerational long QT syndrome pedigree identifies a novel LQT2-causative deeply intronic KCNH2 variant	11
Early mortality after inpatient versus outpatient catheter ablation in patients with atrial fibrillation	11
Etiology and prognosis of patients with unexplained syncope and mid-range left ventricular dysfunction	11
Simultaneous conduction system pacing and atrioventricular node ablation via axillary vs femoral access	11
Left bundle branch area pacing in patients with atrioventricular conduction disease: A prospective multicenter study	11
Flecainide in patients with arrhythmic mitral valve syndrome: A case series	11
Arrhythmogenic mechanisms of acute obstructive respiratory events in a porcine model of drug-induced long QT	11